News Results
There are 793,393 News Results
Dec 8, 2024
New analysis from Phase 3 CEPHEUS study demonstrates 85 percent of patients who achieved MRD negativity (10(-6)) with DARZALEX FASPRO
Jan 29, 2025
Hess Corporation (NYSE: HES) today reported net income of $542 million, or $1.76 per share, in the fourth quarter of 2024, compared with net income of $413 million, or $1.34...
Jan 30, 2025
L3Harris Technologies (NYSE: LHX) reported fourth quarter 2024 diluted EPS of $2.37 on fourth quarter 2024 revenue of $5.5 billion. Fourth quarter 2024 non-GAAP diluted EPS was $3.47. Fourth quarter...
Feb 20, 2025
HNI Corporation (NYSE: HNI) today announced net sales of $2.526 billion and net income of $139.5 million for the full year ended December 28, 2024. Fourth quarter net sales and...
Feb 28, 2025
Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade” or the “Fund”) today announced results for the three- and twelve-month periods ended December 31, 2024. The financial statements and MD&A will be...
May 13, 2025
Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade” or the “Fund”) today announced results for the three-month period ended March 31, 2025. The financial statements and MD&A will be available on...
May 19, 2025
16 abstracts, including two oral presentations, feature new clinical data from Astellas' oncology portfolio
Aug 15, 2025
Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade” or the “Fund”) today announced results for the three-month period ended June 30, 2025. The financial statements and MD&A will be available on...
Feb 21, 2019
SANTA CLARA, Calif., Feb. 21, 2019 /PRNewswire/ --
Jun 27, 2024
KEYTRUDA plus LENVIMA is the first and only combination for the first-line treatment of advanced renal cell carcinoma (RCC) with data in both clear cell and non-clear cell RCC in...
